Robert John Simes

20PUBLICATIONS
108CO-AUTHORS
Epidemiological methodsGenomics and transcriptomicsMolecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 22, 2026
Online tool for refining socio-economic analyses better than postcodes: the example of cardiovascular disease in type 2 diabetes in the FIELD trial.

|Jul 20, 2026
Expression Signatures of Vascular Complication-Associated Proteins in Type 2 Diabetes: A Multiomics Analysis From the FIELD Study.

|Jul 10, 2026
Enhancing Outcome Measurement in Oncology Clinical Trials Through Artificial Intelligence: A Scoping Review.

|Jul 06, 2026
Time to Treatment Failure as an End Point in Pragmatic Oncology Trials: Association With Progression-Free Survival Across Randomized Studies.

|Jun 16, 2026
Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.

|Feb 18, 2026
Time to achieve response and depth of maximal tumor response as potential surrogates for overall survival in advanced non-small cell lung cancer.

Rachel Woodford, Sally Lord, Tom John

Pageof 4

Frequent Collaborators

6 joint publications

Frank Po-Yen Lin

5 joint publications

Chee Khoon Lee

4 joint publications

Rachel Woodford

4 joint publications

Mandy L Ballinger